Wockhardt News - Latest Updates & Headlines
'Zaynich' antibiotic for multi-drug resistant infections to get USFDA approval next year: Wockhardt Chairman Habib Khorakiwala
Dubai, April 12: Habib Khorakiwala, Chairman of Indian pharmaceutical company Wockhardt, on Friday said 'Zaynich,' its medicine for multi-drug resistant infections, is set to get the US Food and Drug Administration (USFDA) approval next year.
Any tariffs on pharma sector would be counterproductive for Americans: Wockhardt Chairman Habib Khorakiwala
Dubai, April 12: Habib Khorakiwala, Chairman of pharma company Wockhardt on Friday indicated that any imposition of tariffs on pharma products by the US administration would be counterproductive for the Americans.
It will be challenge to pharma industry: Wockhardt's Huzaifa Khorakiwala on impact of US tariffs
Dubai, April 12: Dr Huzaifa Khorakiwala, Executive Director of Wockhardt Limited, on Saturday said that imposition of US reciprocal tariffs, if extended on the Indian pharmaceutical products, will pose a significant challenge on the industry.